These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 28007451)

  • 1. Quantitative Changes in Pigment Epithelial Detachment Area and Volume Predict Retreatment in Polypoidal Choroidal Vasculopathy.
    Chan EW; Eldeeb M; Lingam G; Thomas D; Bhargava M; Chee CK
    Am J Ophthalmol; 2017 May; 177():195-205. PubMed ID: 28007451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravitreal bevacizumab in vascular pigment epithelium detachment as a result of subfoveal occult choroidal neovascularization in age-related macular degeneration.
    Ach T; Hoeh AE; Ruppenstein M; Kretz FT; Dithmar S
    Retina; 2010 Oct; 30(9):1420-5. PubMed ID: 20543764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prospective PED-study of intravitreal aflibercept for refractory vascularized pigment epithelium detachment due to age-related macular degeneration: morphologic characteristics of non-responders in optical coherence tomography.
    Clemens CR; Alten F; Termühlen J; Mihailovic N; Rosenberger F; Heiduschka P; Eter N
    Graefes Arch Clin Exp Ophthalmol; 2020 Jul; 258(7):1411-1417. PubMed ID: 32306096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. THE OCCURRENCE, CHARACTERISTICS, MANAGEMENT, AND PROGNOSIS OF RETINAL PIGMENT EPITHELIUM TEARS IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY: A Retrospective Study of 397 Patients.
    Zhao XY; Xia S; Luo MY; Wang EQ; Chen YX
    Retina; 2020 Mar; 40(3):477-489. PubMed ID: 30475788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ranibizumab for vascularized pigment epithelial detachment: 1-year anatomic and functional results.
    Chevreaud O; Oubraham H; Cohen SY; Jung C; Blanco-Garavito R; Gherdaoui F; Souied EH
    Graefes Arch Clin Exp Ophthalmol; 2017 Apr; 255(4):743-751. PubMed ID: 27913869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-year course of subfoveal pigment epithelial detachment in eyes with age-related macular degeneration and visual acuity better than 20/40.
    Baba T; Kitahashi M; Kubota-Taniai M; Oshitari T; Yamamoto S
    Ophthalmologica; 2012; 228(2):102-9. PubMed ID: 22508168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.
    Freeman WR; Kozak I; Yuson RM; Nigam N; Cheng L; Mojana F
    Retina; 2011 Oct; 31(9):1812-8. PubMed ID: 21866073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ranibizumab Treatment for Pigment Epithelial Detachment Secondary to Neovascular Age-Related Macular Degeneration: Post Hoc Analysis of the HARBOR Study.
    Sarraf D; London NJ; Khurana RN; Dugel PU; Gune S; Hill L; Tuomi L
    Ophthalmology; 2016 Oct; 123(10):2213-24. PubMed ID: 27566855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Polypoidal Choroidal Vasculopathy and Anti-Vascular Endothelial Growth Factor Treatment Response in Caucasians.
    Kokame GT; Liu K; Kokame KA; Kaneko KN; Omizo JN
    Ophthalmologica; 2020; 243(3):178-186. PubMed ID: 31707394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting 2-year treatment results of ranibizumab therapy for polypoidal choroidal vasculopathy in eyes with good baseline visual acuity.
    Mori R; Tanaka K; Yuzawa M
    Medicine (Baltimore); 2018 Jun; 97(25):e11188. PubMed ID: 29924037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time-lag between subretinal fluid and pigment epithelial detachment reduction after polypoidal choroidal vasculopathy treatment.
    Chae JB; Lee JY; Yang SJ; Kim JG; Yoon YH
    Korean J Ophthalmol; 2011 Apr; 25(2):98-104. PubMed ID: 21461221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WRINKLED VASCULARIZED RETINAL PIGMENT EPITHELIUM DETACHMENT PROGNOSIS AFTER INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
    Lam D; Semoun O; Blanco-Garavito R; Jung C; Nguyen DT; Souied EH; Mimoun G
    Retina; 2018 Jun; 38(6):1100-1109. PubMed ID: 28520639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-year outcomes of intravitreal conbercept therapy for polypoidal choroidal vasculopathy.
    Liu Y; Guo J; Tang W; Xu G; Liu W
    BMC Ophthalmol; 2024 Oct; 24(1):441. PubMed ID: 39379869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective clinical trial of Intravitreal aflibercept treatment for PolypoIdal choroidal vasculopathy with hemorrhage or exudation (EPIC study): 6 month results.
    Kokame GT; Lai JC; Wee R; Yanagihara R; Shantha JG; Ayabe J; Hirai K
    BMC Ophthalmol; 2016 Jul; 16():127. PubMed ID: 27465105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CORRELATION BETWEEN OPTICAL COHERENCE TOMOGRAPHIC HYPERREFLECTIVE FOCI AND VISUAL OUTCOMES AFTER ANTI-VEGF TREATMENT IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION AND POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Lee H; Ji B; Chung H; Kim HC
    Retina; 2016 Mar; 36(3):465-75. PubMed ID: 26076214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EFFICACY OF INTRAVITREAL INJECTION OF CONBERCEPT IN POLYPOIDAL CHOROIDAL VASCULOPATHY: Subgroup Analysis of the Aurora Study.
    Qu J; Cheng Y; Li X; Yu L; Ke X;
    Retina; 2016 May; 36(5):926-37. PubMed ID: 26595362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Volumetric Analysis of Vascularized Serous Pigment Epithelial Detachment Progression in Neovascular Age-Related Macular Degeneration Using Optical Coherence Tomography Angiography.
    Au A; Hou K; Dávila JP; Gunnemann F; Fragiotta S; Arya M; Sacconi R; Pauleikhoff D; Querques G; Waheed N; Freund KB; Sadda S; Sarraf D
    Invest Ophthalmol Vis Sci; 2019 Aug; 60(10):3310-3319. PubMed ID: 31369033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term visual outcome and prognostic factors after intravitreal ranibizumab injections for polypoidal choroidal vasculopathy.
    Kang HM; Koh HJ
    Am J Ophthalmol; 2013 Oct; 156(4):652-60. PubMed ID: 23891333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging characteristics of neovascular pigment epithelial detachments and their response to anti-vascular endothelial growth factor therapy.
    Punjabi OS; Huang J; Rodriguez L; Lyon AT; Jampol LM; Mirza RG
    Br J Ophthalmol; 2013 Aug; 97(8):1024-31. PubMed ID: 23759437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CHARACTERIZING THE EFFECT OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY ON TREATMENT-NAIVE CHOROIDAL NEOVASCULARIZATION USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.
    Muakkassa NW; Chin AT; de Carlo T; Klein KA; Baumal CR; Witkin AJ; Duker JS; Waheed NK
    Retina; 2015 Nov; 35(11):2252-9. PubMed ID: 26457400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.